ACS HEALTHSOLUTIONS LIMITED
- · Thesis: well-run, low negotiation leverage
Opportunity 74/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2025-02-28 | 2024-02-28 |
|---|---|---|
| Total assets | £92.6k | £55.5k |
| Current assets | £360.1k | £352.0k |
| Net assets | £92.6k | £35.8k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
Corporate timeline (18 events)Click to expand
- 2025-11-04📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-10-22📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-07-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-05-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-10-13📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-06-10📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-10-29📄accounts-amended-with-accounts-type-micro-entityaccounts · AAMD
- 2019-07-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-11-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-12-22📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2016-11-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2016-03-04📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-11-30📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-02-23📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-11-28📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2013-06-11➕COLLADO, Cesar appointeddirector
- 2012-02-09🏢Company incorporatedAs ACS HEALTHSOLUTIONS LIMITED
- 2012-02-09➕COLLADO, Maria Sheriel appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
- +No director turnover: Company is 14 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- secondary12+ year tenure: Director in role 14 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Cesar Collado Individual · British · DOB 05/1972 · age 54 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 06/04/2016 |
Mrs Maria Collado Individual · British · DOB 11/1973 · age 53 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · L postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 365 HEALTH DEVELOPMENTS LIMITED→ 11436035 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ABOYJAY LTD→ 15973742 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ABUNDANTIA CARE LIMITED→ 11591160 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ACCESS TO CARE LIMITED→ 05867774 · est 2006 · no financials extracted | — | — | — | — | 19y | — | — |
| ACCOLADE MIDLAND LTD→ 16430795 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ACCREDITED AESTHETIC TRAINING LIMITED→ 09085219 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| ACER CLINICAL MICROBIOLOGY SERVICES LTD→ 09652331 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| ACM IMAGING LTD→ 14381916 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ACORN CHILDREN CARE LTD→ 17099010 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ACT PHARMA LIMITED→ 14002981 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ACTIVE COMMUNITY ENTERPRISE (A.C.E.) COMMUNITY INTEREST COMPANY→ 06950215 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| ACTIVE MINDS DAY CENTRE CIC→ 12946458 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.